EMA encourages companies to submit type I variations for 2024 by end November 2024
EMA is advising marketing authorisation holders to submit type IA and type IAIN variations for 2024 no later than 30 November 2024. This will enable EMA to acknowledge the…, Related documents European Medicines Agency practical guidance on the application form for centralised type IA and IB variationsReference Number: EMA/233564/2014…
